Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Evobrutinib in Participants With RMS (evolutionRMS 1)

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
relapsing multiple sclerosis, evobrutinib, teriflunomide, aubagio®, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 853104
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.